The United Arab Emirates will start producing the Chinese Sinopharm Covid-19 vaccine from April, helping the Gulf state accelerate plans to supply coronavirus jabs around the world.
Gulf Pharmaceutical Industries, also known as Julphar, said on Sunday it had signed a contract with Abu Dhabi’s G42 to produce the vaccine, which was trialled in the UAE and has since driven the country’s successful vaccination campaign.
The UAE, which began administering the jab to healthcare professionals last September, became the first country to approve Sinopharm for general use in December, saying it was 86 per cent effective in preventing Covid-19.
您已閱讀22%（639字），剩余78%（2330字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。